4/24
07:33 am
nuro
NeuroMetrix, Inc.'s (NASDAQ:NURO) CEO Might Not Expect Shareholders To Be So Generous This Year [Yahoo! Finance]
Medium
Report
NeuroMetrix, Inc.'s (NASDAQ:NURO) CEO Might Not Expect Shareholders To Be So Generous This Year [Yahoo! Finance]
4/19
09:18 am
nuro
NeuroMetrix names new independent director, terminates equity program; shares up [Seeking Alpha]
Medium
Report
NeuroMetrix names new independent director, terminates equity program; shares up [Seeking Alpha]
4/19
08:19 am
nuro
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value [Yahoo! Finance]
Medium
Report
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value [Yahoo! Finance]
4/19
08:00 am
nuro
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
High
Report
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
4/18
02:03 am
nuro
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/10
02:03 am
nuro
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/14
09:13 am
nuro
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy [Yahoo! Finance]
Medium
Report
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy [Yahoo! Finance]
3/14
09:00 am
nuro
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
Medium
Report
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
3/13
02:21 pm
nuro
Point Of Care Diagnostics Market By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End-use (Clinics, Home, Hospitals), By Region, And Segment Forecasts, 2024 - 2030 [Yahoo! Finance]
Low
Report
Point Of Care Diagnostics Market By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End-use (Clinics, Home, Hospitals), By Region, And Segment Forecasts, 2024 - 2030 [Yahoo! Finance]
3/13
09:22 am
nuro
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia [Yahoo! Finance]
Low
Report
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia [Yahoo! Finance]
3/13
09:00 am
nuro
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
Low
Report
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
3/12
08:17 am
nuro
Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired [Yahoo! Finance]
Medium
Report
Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired [Yahoo! Finance]
3/12
08:00 am
nuro
Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired
Medium
Report
Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired
3/8
12:25 pm
nuro
RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc. [Yahoo! Finance]
Low
Report
RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc. [Yahoo! Finance]
3/8
11:00 am
nuro
RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc.
Low
Report
RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc.
3/4
08:16 am
nuro
Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc. [Yahoo! Finance]
High
Report
Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc. [Yahoo! Finance]
3/4
08:00 am
nuro
Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc.
Low
Report
Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc.
2/24
09:04 am
nuro
NeuroMetrix Full Year 2023 Earnings: US$6.08 loss per share (vs US$4.96 loss in FY 2022) [Yahoo! Finance]
High
Report
NeuroMetrix Full Year 2023 Earnings: US$6.08 loss per share (vs US$4.96 loss in FY 2022) [Yahoo! Finance]
2/23
11:36 am
nuro
NeuroMetrix, Inc. (NASDAQ:NURO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
NeuroMetrix, Inc. (NASDAQ:NURO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/22
07:06 am
nuro
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights [Yahoo! Finance]
High
Report
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights [Yahoo! Finance]
2/22
07:00 am
nuro
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights
High
Report
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights
2/19
02:07 am
nuro
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/15
09:00 am
nuro
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call
Medium
Report
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call
2/13
09:16 am
nuro
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value [Yahoo! Finance]
Medium
Report
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value [Yahoo! Finance]
2/13
09:00 am
nuro
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value
High
Report
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value